SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (897)11/19/2003 12:50:10 PM
From: tuck  Read Replies (1) | Respond to of 3557
 
A little something to watch for in the next few days:

>>Annette T. Byrne, Leorah Ross, Joceyln Holash, Mikiye Nakanishi, Limin Hu, Judith I. Hoffman, George D. Yancopoulos, and Robert B. Jaffe

VEGF-Trap Decreases Tumor Burden, Inhibits Ascites Caused by Either Endogenous or Genetically Delivered VEGF, and Causes Dramatic Vascular Remodeling in an Ovarian Cancer Model <<

Upcoming in Clinical Cancer Research Nov. 15 issue.

Cheers, Tuck